T-cell responses associated with neonatal alloimmune thrombocytopenia: Isolation of HPA-1a-specific, HLA-DRB3*0101-restricted CD4+ T cells

Blood

Volumn 113, Issue 16, 2009, Pages 3838-3844

  Ahlen, Maria Therese ^a,b   Husebekk, Anne ^a,b   Killie, Mette Kjær ^a   Skogen, Bjørn ^a,b   Stuge, Tor B ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; HLA DR3 ANTIGEN; HUMAN PLATELET ANTIGEN 1; SYNTHETIC PEPTIDE; THROMBOCYTE ANTIGEN; UNCLASSIFIED DRUG; CYTOKINE; HLA DR ANTIGEN; HLA DRB3; HLA-DRB3; PEPTIDE;

ALLOIMMUNIZATION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; NEWBORN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; ADULT; CELL CULTURE; CELL PROLIFERATION; IMMUNOLOGY;

ADULT; ANTIGENS, HUMAN PLATELET; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; FEMALE; HLA-DR ANTIGENS; HUMANS; INFANT, NEWBORN; PEPTIDES; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

EID: 65549148250     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-09-178475     Document Type: Article

References (24)

1. Williamson LM, Hackett G, Rennie J, et al. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood. 1998;92:2280-2287. (Pubitemid 28452968)
2. L'Abbe D, Tremblay L, Filion M, et al. Alloimmunization to platelet antigen HPA-1a (PIA1) is strongly associated with both HLA-DRB3*0101 and HLA-DQB1* 0201. Hum Immunol. 1992;34:107-114.
3. Ghevaert C, Campbell K, Walton J, et al. Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia. Transfusion. 2007;47:901-910. (Pubitemid 46669006)
4. Bussel JB, Berkowitz RL, Lynch L, et al. Antenatal management of alloimmune thrombocytopenia with intravenous [gamma]-globulin: a randomized trial of the addition of low-dose steroid to intravenous [gamma]-globulin. Am J Obstet Gynecol. 1996;174:1414-1423. (Pubitemid 26165254)
5. Yinon Y, Spira M, Solomon O, et al. Antenatal noninvasive treatment of patients at risk for allo-immune thrombocytopenia without a history of intracranial hemorrhage. Am J Obstet Gynecol. 2006;195:1153-1157. (Pubitemid 44430088)
6. Kjeldsen-Kragh J, Killie MK, Tomter G, et al. A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood. 2007;110:833-839.
7. Valentin N, Vergracht A, Bignon JD, et al. HLA-DRw52a is involved in alloimmunization against PL-A1 antigen. Hum Immunol. 1990;27:73-79. (Pubitemid 20030177)
8. Bertrand G, Jallu V, Gouet M, et al. Quantification of human platelet antigen-1a antibodies with the monoclonal antibody immobilization of platelet antigens procedure. Transfusion. 2005;45:1319-1323. (Pubitemid 41647797)
9. Jægtvik S, Husebekk A, Aune B, Øian P, Dahl L, Skogen B. Neonatal alloimmune thrombocytopenia due to anti-HPA 1a antibodies; the level of maternal antibodies predicts the severity of thrombocytopenia in the newborn. BJOG. 2000; 107:691-694.
10. Parry CS, Gorski J, Stern LJ. Crystallographic structure of the human leukocyte antigen DRA, DRB3*0101: models of a directional alloimmune response and autoimmunity. J Mol Biol. 2007; 371:435-446. (Pubitemid 47048269)
11. Wu S, Maslanka K, Gorski J. An integrin polymorphism that defines reactivity with alloantibodies generates an anchor for MHC class II peptide binding: a model for unidirectional alloimmune responses. J Immunol. 1997;158:3221-3226. (Pubitemid 127484037)
12. Herzenberg LA, Tung J, Moore WA, Herzenberg LA, Parks DR. Interpreting flow cytometry data: a guide for the perplexed. Nat Immunol. 2006;7: 681-685. (Pubitemid 43905862)
13. Lee KH, Panelli MC, Kim CJ, et al. Functional dissociation between local and systemic immune response during anti-melanoma peptide vaccination. J Immunol. 1998;161:4183-4194.
14. Stuge TB, Holmes SP, Saharan S, et al. Diversity and recognition efficiency of T cell responses to cancer. PLoS Med. 2004;1:e28.
15. Giudicelli V, Chaume D, Lefranc MP. IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis. Nucleic Acids Res. 2004;32:W435-W440. (Pubitemid 38997372)
16. Traggiai E, Becker S, Subbarao K, et al. An efficient method to make human monoclonal anti-bodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med. 2004;10: 871-875. (Pubitemid 39070862)
17. Jackson DJ, Murphy MF, Soothill PW, Lucas GF, Elson CJ, Kumpel BM. Reactivity of T cells from women with antibodies to the human platelet antigen (HPA)-1a to peptides encompassing the HPA-1 polymorphism. Clin Exp Immunol. 2005; 142:92-102.
18. Maslanka K, Yassai M, Gorski J. Molecular identification of T cells that respond in a primary bulk culture to a peptide derived from a platelet glyco-protein implicated in neonatal alloimmune thrombocytopenia. J Clin Invest. 1996;98:1802-1808. (Pubitemid 26359197)
19. Sukati H, Bessos H, Barker RN, Urbaniak SJ. Characterization of the alloreactive helper T-cell response to the platelet membrane glycoprotein IIIa (integrin-beta3) in human platelet antigen- 1a alloimmunized human platelet antigen- 1b1b women. Transfusion. 2005;45:1165-1177. (Pubitemid 40935017)
20. Lee ST, Liu S, Radvanyi L, et al. A novel strategy for rapid and efficient isolation of human tumor-specific CD4+ and CD8+ T-cell clones. J Immunol Methods. 2008;331:13-26. (Pubitemid 351226188)
21. Mannering SI, Dromey JA, Morris JS, Thearle DJ, Jensen KP, Harrison LC. An efficient method for cloning human autoantigen-specific T cells. J Immunol Methods. 2005;298:83-92. (Pubitemid 40545095)
22. Killie MK, Husebekk A, Kjeldsen-Kragh J, Skogen B. A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn. Haematologica. 2008;93:870-877. (Pubitemid 351821723)
23. Raghupathy R, Makhseed M, Azizieh F, Hassan N, Al Azemi M, Al Shamali E. Maternal Th1- and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cell Immunol. 1999;196: 122-130. (Pubitemid 29496461)
24. Giudicelli V, Chaume D, Lefranc MP. IMGT/ GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. Nucleic Acids Res. 2005;33:D256-D261.